| CMM |
|
cutaneous malignant melanoma/dysplastic nevus
|
|
|
0.670 |
0.385 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| MLRL |
|
Myeloid leukemia-related gene (myeloid tumor suppressor)
|
|
|
0.564 |
0.769 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| SNHG3 |
|
small nucleolar RNA host gene 3
|
|
|
0.682 |
0.385 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| LINC00328 |
|
long intergenic non-protein coding RNA 328
|
|
|
0.608 |
0.692 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| RBPJP4 |
|
RBPJ pseudogene 4
|
|
|
0.805 |
0.423 |
| BRCA3 |
|
breast cancer 3
|
|
|
0.705 |
0.269 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
| HAND2-AS1 |
|
HAND2 antisense RNA 1
|
|
|
0.663 |
0.462 |
| FOXD2-AS1 |
|
FOXD2 adjacent opposite strand RNA 1
|
|
|
0.644 |
0.423 |